Cellular Therapies and Stem Cell Processing

Overview

Cellular Therapies and Stem Cell Processing is a specialised service within the Centre of Transfusion Medicine that supports the collection, processing, preservation, testing, storage, and release of cells used for treatment. These therapies are commonly used in hematopoietic stem cell transplantation and selected advanced cancer, blood, immune, and genetic disease treatments.

This service plays a critical role in ensuring that cellular therapy products are handled safely, accurately, and under strict quality standards before they are given to a patient.

What Are Cellular Therapies and Stem Cell Processing?

Cellular therapy uses living cells to treat disease, repair damaged tissue, or restore blood and immune system function. Stem cell processing involves preparing collected stem cells or immune cells so they are suitable for clinical use.

The process may include:

• Stem cell collection through apheresis or bone marrow harvest

• Processing of peripheral blood stem cells, bone marrow, or cord blood

• Cell counting and viability testing

• Removal or reduction of unwanted components when required

• Cryopreservation, or freezing cells for future use

• Controlled storage in specialised freezers or liquid nitrogen systems

• Product labelling, tracking, and documentation

• Release testing before infusion

• Coordination with transplant, hematology, oncology, and laboratory teams

Cellular therapy products may be used for autologous treatment, where the patient’s own cells are used, or allogeneic treatment, where cells come from a donor.

Causes and Risk Factors

Cellular therapies may be considered for patients with diseases where the blood, bone marrow, immune system, or certain cancers require advanced treatment.

Common reasons for referral include:

• Leukemia

• Lymphoma

• Multiple myeloma

• Bone marrow failure syndromes

• Severe aplastic anaemia

• Certain inherited blood or immune disorders

• Selected metabolic or genetic disorders

• Need for hematopoietic stem cell transplantation

• Need for immune effector cell therapy, such as CAR T-cell therapy in selected cases

• Relapsed or high-risk blood cancers requiring specialised treatment

Suitability depends on the diagnosis, disease stage, previous treatment, organ function, infection status, donor availability, and overall fitness for therapy.

Symptoms

Cellular Therapies and Stem Cell Processing are not usually recommended based on symptoms alone. They are considered after a confirmed diagnosis and specialist evaluation.

Patients being evaluated may have symptoms related to blood cancers, bone marrow failure, or immune system disorders, such as:

• Persistent fatigue or weakness

• Frequent infections

• Easy bruising or bleeding

• Unexplained fever

• Swollen lymph nodes

• Bone pain

• Unexplained weight loss

• Anaemia or low blood counts

• Poor response to standard treatment

• Relapsed or progressive disease

Urgent medical care is needed for severe infection, uncontrolled bleeding, extreme weakness, breathlessness, confusion, seizures, or rapidly worsening health.

Diagnosis

Before cellular therapy or stem cell processing, the medical team performs detailed testing to confirm eligibility and ensure safe collection, processing, and infusion.

Common assessments include:

• Complete blood count and blood smear

• Bone marrow examination when required

• Disease-specific tests, including cytogenetic or molecular testing

• Blood group and antibody screening

• HLA typing for donor-recipient matching

• Infection screening for patient and donor safety

• Kidney, liver, heart, and lung function assessment

• Assessment of vein access for apheresis

• Stem cell mobilisation response monitoring

• Cell count, CD34 testing, and viability testing

• Sterility and microbial contamination testing where applicable

• Product identity, labelling, and traceability checks

Strict documentation and quality control are essential to ensure that the correct cellular product is safely processed and released for the correct patient.

Treatment Options

Treatment depends on the underlying disease and the type of cellular therapy being planned.

Cellular therapy support may include:

• Autologous stem cell collection and processing

• Allogeneic donor stem cell collection and processing

• Peripheral blood stem cell apheresis

• Bone marrow processing

• Cord blood processing in selected settings

• Cryopreservation and long-term storage of cells

• Thawing and preparation before infusion

• Processing support for immune effector cell therapies

• Quality testing before product release

• Coordination with transplant physicians for stem cell infusion

• Monitoring and documentation of adverse events or product-related issues

The Centre of Transfusion Medicine works behind the scenes to maintain product quality, chain of identity, chain of custody, and patient safety throughout the process.

Prevention and Outlook

Cellular therapy services do not prevent disease, but they support advanced treatment options for selected patients with serious blood, immune, and cancer-related conditions. Good outcomes depend on accurate diagnosis, proper patient selection, safe collection, high-quality processing, infection control, and close coordination between clinical and laboratory teams.

The outlook varies depending on the disease, type of cellular therapy, patient age, treatment response, donor match, and complications. With modern processing standards and quality systems, cellular therapies have become an important part of personalised and advanced medical care.

Frequently Asked Questions

1. What is stem cell processing?
   Stem cell processing is the laboratory preparation of collected stem cells so they can be safely stored, tested, and infused into a patient when needed.

2. What is the difference between autologous and allogeneic stem cell therapy?
   Autologous therapy uses the patient’s own cells. Allogeneic therapy uses cells from a donor, usually after matching tests are done.

3. How are stem cells collected?
   Stem cells may be collected from the blood using apheresis, from bone marrow through a harvest procedure, or from cord blood in selected cases.

4. Why are stem cells frozen?
   Stem cells are frozen through cryopreservation so they can be stored safely and used later for treatment.

5. What safety checks are done before infusion?
   Checks may include cell count, viability, sterility testing, blood group compatibility, labelling verification, identity confirmation, and medical review before release.

6. Is cellular therapy the same as blood transfusion?
   No. Both are managed with strict transfusion medicine safety systems, but cellular therapy involves living cells used for specialised treatment, while blood transfusion replaces blood components such as red cells, platelets, or plasma.